Optivar and Lipitor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Optivar (azelastine hydrochloride) and Lipitor (atorvastatin calcium). Common drug interactions include somnolence among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Optivar and Lipitor. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Optivar?

Optivar has active ingredients of azelastine hydrochloride. eHealthMe is studying from 367 Optivar users. Check the latest studies of Optivar.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,050 Lipitor users. Check the latest studies of Lipitor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

35 people who take Optivar and Lipitor together, and have interactions are studied.

Optivar and Lipitor drug interactions.

What are the common drug interactions of Optivar and Lipitor, by gender? *:

female:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Stress
  3. Swelling
  4. Therapeutic response decreased (less preventive response)
  5. Tooth disorder (tooth disease)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Tunnel vision (the loss of peripheral vision with retention of central vision)
  8. Sinusitis (inflammation of sinus)
  9. Candidiasis (candidiasis or thrush is a fungal infection)
  10. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)

male:

  1. Acute respiratory failure
  2. Anaemia (lack of blood)
  3. Proteinuria (presence of protein in the urine)
  4. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Vomiting
  7. Weight decreased
  8. Eating disorder
  9. Weight increased
  10. Death

What are the common drug interactions of Optivar and Lipitor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Sinusitis (inflammation of sinus)
  2. Candidiasis (candidiasis or thrush is a fungal infection)
  3. Upper respiratory tract infection
  4. Abdominal pain
  5. Back pain
  6. Constipation
  7. Gastric ulcer (stomach ulcer)
  8. Oedema peripheral (superficial swelling)
  9. Oral candidiasis (fungal infection of mouth)
  10. Pain in extremity

50-59:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Haemoglobin decreased
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Pneumonia
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Urinary tract infection
  8. Chronic kidney disease
  9. Deafness
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

60+:

  1. Hypoglycaemia (deficiency of glucose in the bloodstream)
  2. Acute respiratory failure
  3. Proteinuria (presence of protein in the urine)
  4. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Vomiting
  7. Weight decreased
  8. Eating disorder
  9. Weight increased
  10. Death

What are the existing conditions these people have? *

  1. Pain: 7 people, 20.00%
  2. Hypersensitivity: 7 people, 20.00%
  3. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 17.14%
  4. Diabetes: 6 people, 17.14%
  5. Dry Eyes (lack of adequate tears): 5 people, 14.29%
  6. Oedema (fluid collection in tissue): 5 people, 14.29%
  7. Depression: 5 people, 14.29%
  8. Metastases To Central Nervous System (cancer spreads to central nervous system): 5 people, 14.29%
  9. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 11.43%
  10. Immunodeficiency: 4 people, 11.43%

* Approximation only. Some reports may have incomplete information.

Do you take Optivar and Lipitor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Optivar and Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Optivar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Optivar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on azelastine hydrochloride and atorvastatin calcium (the active ingredients of Optivar and Lipitor, respectively), and Optivar and Lipitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: